Enfortumab vedotin-ejfv (Padcev) has been approved for people with advanced bladder cancer. FDA granted the drug accelerated approval for cancers that have progressed despite previous treatments.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2t7ZBEx
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2t7ZBEx